logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Xima Medical (03309.HK) spent 392,900 Hong Kong dollars on September 15 to repurchase 200,000 shares.

date
15/09/2025
China Fortune Finance and Economics APP News, Hima Medical (03309.HK) announced that it will spend 392,900 Hong Kong dollars to repurchase 200,000 shares on September 15, 2025.
Latest
2 m ago
Southwest Securities: Xizheng International Securities will no longer have listed status as of September 29th.
3 m ago
Anthurium: Wholly-owned subsidiary has obtained the registration certificate for Clindamycin hydrochloride palmitate particles.
4 m ago
Zhongyuan Home: Cao Yong intends to reduce his shareholding by no more than 3%
4 m ago
Hainan Airlines Group: Passenger transport capacity in August increased by 3.38% year-on-year.
4 m ago
Shandong province initiates level four flood control emergency response.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.